{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:55:35Z","timestamp":1790963735933,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12012-016-9387-6","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T13:16:46Z","timestamp":1477401406000},"page":"307-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-678X","authenticated-orcid":false,"given":"D. L.","family":"Misner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Kauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bruening-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Liederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. S.","family":"Dragovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S.","family":"Zabka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"key":"9387_CR1","unstructured":"Bair, K., Baumeister, T. R., Dragovich, P., Gosselin, F., Yuen, P. W., Zak, M., et al. (2013). Preparation of pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives as NAMPT inhibitors. WO2013127267."},{"key":"9387_CR2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2174\/092986711795590101","volume":"18","author":"ES Burgos","year":"2011","unstructured":"Burgos, E. S. (2011). NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. Current Medicinal Chemistry, 18, 1947\u20131961.","journal-title":"Current Medicinal Chemistry"},{"key":"9387_CR3","doi-asserted-by":"crossref","first-page":"22408","DOI":"10.1074\/jbc.M112.357301","volume":"287","author":"D Cerna","year":"2012","unstructured":"Cerna, D., Li, H., Flaherty, S., Takebe, N., Coleman, C. N., & Yoo, S. S. (2012). Inihibition of nicotinamide phosphoryltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner. Journal of Biological Chemistry, 287, 22408\u201322417.","journal-title":"Journal of Biological Chemistry"},{"key":"9387_CR4","first-page":"7436","volume":"63","author":"M Hasmann","year":"2003","unstructured":"Hasmann, M., & Schemainda, I. (2003). FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoryltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Research, 63, 7436\u20137442.","journal-title":"Cancer Research"},{"key":"9387_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10637-007-9083-2","volume":"26","author":"K Holen","year":"2008","unstructured":"Holen, K., Saltz, L. B., Hollywood, E., Burk, K., & Hanauske, A. R. (2008). The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Investigational New Drugs, 26, 45\u201351.","journal-title":"Investigational New Drugs"},{"key":"9387_CR6","first-page":"2843","volume":"8","author":"P Hovstadius","year":"2002","unstructured":"Hovstadius, P., Larsson, R., Jonsson, E., Skov, T., Kissmeyer, A. M., Krasilnikoff, K., et al. (2002). A phase I study of CHS 828 in patients with solid tumor malignancy. Clinical Cancer Research, 8, 2843\u20132850.","journal-title":"Clinical Cancer Research"},{"key":"9387_CR7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","volume":"105","author":"CP Hsu","year":"2009","unstructured":"Hsu, C. P., Oka, S., Shao, D., Hariharan, N., & Sodoshima, J. (2009). Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circulation Research, 105, 481\u2013491.","journal-title":"Circulation Research"},{"key":"9387_CR8","doi-asserted-by":"crossref","first-page":"11.12.1","DOI":"10.1002\/0471141755.ph1112s64","volume-title":"Current protocols in pharmacology","author":"AG Kirsch","year":"2014","unstructured":"Kirsch, A. G., Obejero-Paz, C. A., & Bruening-Wright, A. (2014). Functional characterization of human stem cell-derived cardiomyocytes. In S. J. Enna, M. Williams, T. Kenakin, P. McGonigle, & B. Ruggeri (Eds.), Current protocols in pharmacology (pp. 11.12.1\u201311.12.26). San Francisco, CA: Wiley."},{"key":"9387_CR9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11936-014-0334-1","volume":"16","author":"JS Leyton-Mange","year":"2014","unstructured":"Leyton-Mange, J. S., & Milan, D. J. (2014). Pluripotent stem cells as a platform for cardiac arrhythmia drug screening. Current Treatment Options in Cardiovascular Medicine, 16, 334\u2013352.","journal-title":"Current Treatment Options in Cardiovascular Medicine"},{"key":"9387_CR10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.14.8","volume":"6","author":"X Liang","year":"2014","unstructured":"Liang, X., Yang, L., Qin, A. R., Ly, J., Liederer, B. M., Messick, K., et al. (2014). Measuring NAD+ levels in mouse blood and tissue samples via a surrogate matrix approach using LC-MS\/MS. Bioanalysis, 6, 1445\u20131457.","journal-title":"Bioanalysis"},{"key":"9387_CR11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1593\/neo.131718","volume":"15","author":"T O\u2019Brien","year":"2013","unstructured":"O\u2019Brien, T., Oeh, J., Xiao, Y., Liang, X., Vanderbilt, A., Qin, A., et al. (2013). Supplementation of nicotonic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models. Neoplasia, 15, 1314\u20131329.","journal-title":"Neoplasia"},{"key":"9387_CR12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/cbic.201402023","volume":"15","author":"A Oh","year":"2014","unstructured":"Oh, A., Ho, Y. C., Zak, M., Yongbo, L., Chen, X., Yuen, P., et al. (2014). Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase. ChemBioChem, 15, 1121\u20131131.","journal-title":"ChemBioChem"},{"issue":"4\u20135","key":"9387_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0463.2011.02733.x","volume":"119","author":"UH Olesen","year":"2011","unstructured":"Olesen, U. H., Hastrup, N., Sehested, M. (2011). Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. APMIS, 119(4\u20135), 296\u2013303.","journal-title":"APMIS"},{"key":"9387_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-014-9268-9","author":"MF Peters","year":"2014","unstructured":"Peters, M. F., Lamore, S. D., Guo, L., Scott, C. W., & Kolaja, K. L. (2014). Human stem cell-derived cardiomyocytes in cellular impedance assays: Bringing cardiotoxicity screening to the front line. Cardiovascular Toxicology. doi: 10.1007\/s12012-014-9268-9 .","journal-title":"Cardiovascular Toxicology"},{"key":"9387_CR15","doi-asserted-by":"crossref","first-page":"A3581","DOI":"10.1200\/jco.2009.27.15_suppl.3581","volume":"27","author":"MJ Pishvaian","year":"2009","unstructured":"Pishvaian, M. J., Marshall, J. L., Hwang, J. J., Malik, S., He, A. R., Deeken, J. F., et al. (2009). A phase I trial of GMX1777, an inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT), given as a 24-hour infusion. Journal of Clinical Oncology, 27, A3581.","journal-title":"Journal of Clinical Oncology"},{"key":"9387_CR16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ejca.2004.12.023","volume":"41","author":"A Ravaud","year":"2005","unstructured":"Ravaud, A., Cerny, T., Terret, C., Wanders, J., Nguyen Bui, B., Hess, D., et al. (2005). Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3\u00a0weeks in solid tumours: an ECSG\/EORTC study. European Journal of Cancer, 41, 702\u2013707.","journal-title":"European Journal of Cancer"},{"key":"9387_CR17","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1158\/1078-0432.CCR-13-1186","volume":"19","author":"DS Shames","year":"2013","unstructured":"Shames, D. S., Elkins, K., Walter, K., Holcomb, T., Du, P., Mohl, D., et al. (2013). Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors. Clinical Cancer Research, 19, 6912\u20136923.","journal-title":"Clinical Cancer Research"},{"issue":"Suppl","key":"9387_CR18","first-page":"2179","volume":"52","author":"J Singh","year":"2013","unstructured":"Singh, J., Zabka, T., Uppal, H., Diaz, D., Tarrant, J., Clarke, E., et al. (2013). Effects of nicotinamide phosphoribosyltransferase inhibitors on platelet development. Toxicological Sciences, 52(Suppl), 2179.","journal-title":"Toxicological Sciences"},{"key":"9387_CR19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00280-009-1125-3","volume":"65","author":"A Heideman von","year":"2010","unstructured":"von Heideman, A., Berglund, A., Larsson, R., & Nygren, P. (2010). Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemotherapy and Pharmacology, 65, 1165\u20131172.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9387_CR20","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1128\/MCB.00112-09","volume":"29","author":"M Watson","year":"2009","unstructured":"Watson, M., Roulston, A., Belec, L., Billot, X., Marcellus, R., Bedard, D., et al. (2009). The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: Strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Molecular and Cellular Biology, 29, 5872\u20135888.","journal-title":"Molecular and Cellular Biology"},{"key":"9387_CR21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1593\/neo.131304","volume":"15","author":"Y Xiao","year":"2013","unstructured":"Xiao, Y., Elkins, K., Durieux, J. K., Lee, L., Oeh, J., Yang, L. X., et al. (2013). Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618. Neoplasia, 15, 1151\u20131160.","journal-title":"Neoplasia"},{"key":"9387_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ars.2007.1672","volume":"10","author":"W Ying","year":"2008","unstructured":"Ying, W. (2008). NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: Regulation and biological consequences. Antioxidants and Redox Signaling, 10, 179\u2013206.","journal-title":"Antioxidants and Redox Signaling"},{"issue":"1","key":"9387_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/toxsci\/kfu268","volume":"144","author":"TS Zabka","year":"2015","unstructured":"Zabka, T. S., Singh, J., Dhawan, P., Liederer, B. M., Oeh, J., Kauss, M. A., et al. (2015). Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase. Toxicological Sciences, 144(1), 163\u2013172.","journal-title":"Toxicological Sciences"},{"key":"9387_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4172\/1948-593X.1000038","volume":"3","author":"LQ Zhang","year":"2011","unstructured":"Zhang, L. Q., Heruth, D. P., & Ye, S. Q. (2011). Nicotinamide phosphoribosylatransferase in human diseases. Journal of Bioanalysis and Biomedicine, 3, 13\u201325.","journal-title":"Journal of Bioanalysis and Biomedicine"},{"key":"9387_CR25","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/jm4008664","volume":"56","author":"X Zheng","year":"2013","unstructured":"Zheng, X., Bauer, P., Baumeister, T., Buckmelter, A. J., Caligiuri, M., Clodfelter, K. H., et al. (2013). Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors. Journal of Medicinal Chemistry, 56, 6413\u20136433.","journal-title":"Journal of Medicinal Chemistry"},{"key":"9387_CR26","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1016\/j.bmcl.2013.08.074","volume":"23","author":"X Zheng","year":"2013","unstructured":"Zheng, X., Bair, K. W., Bauer, P., Baumeister, T., Bowman, K. K., Buckmelter, A. J., et al. (2013). Identification of amides derived from 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorganic and Medicinal Chemistry Letters, 23, 5488\u20135497.","journal-title":"Bioorganic and Medicinal Chemistry Letters"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-016-9387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-016-9387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-016-9387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:40:54Z","timestamp":1601160054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-016-9387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["9387"],"URL":"https:\/\/doi.org\/10.1007\/s12012-016-9387-6","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}